N@N

BIOTIME INC (AMEX:BTX), Down By 3.93% ($0.19) From $4.830 After BUYINS.NET Report Predicted Stock Would Go Down Due To Bearish

^{Published on 2011-06-03 05:20:41 - WOPRAI}
 

June 3, 2011 / M2 PRESSWIRE / BUYINS.NET, www.buyins.net , a provider of unique trading technologies, released a report on Thursday, May 26th 2011 stating that BIOTIME INC (AMEX:BTX) was expected to go Down due to the Bearish conditions presented in the following report. Click here to view the BUYINS.NET report: http://www.buyins.net/releases/?sym=btx&id=169129

At the time this story was written, BIOTIME INC (AMEX:BTX) is Down By $0.19 (3.93%) since the BUYINS.NET report was released.

The movement of stock prices in the days and weeks leading to and following specific fundamental or technical events may follow a predictable pattern. Many companies stock price histories show random or unpredictable movements around certain events. But some seem to repeat the same pattern quarter after quarter, year after year. We use powerful computers to uncover those events and correlations to generate predictions with high probabilities of generating very specific returns within very specific time periods.

The specific technology used to make these predictions is available for a low monthly fee at http://www.squeezetrigger.com/services/strat/mh.php

BIOTIME INC (AMEX:BTX) - BioTime, Inc., a biotechnology company, engages in the biomedical research and product development activities in the United States and Asia. It primarily focuses on regenerative medicine, which refers to therapies based on human embryonic stem (hES) cell and induced pluripotent stem (iPS) cell technology designed to rebuild cell and tissue function lost due to degenerative disease or injury. The company develops and markets research products in the field of stem cells and regenerative medicine. It is developing therapeutic products derived from stem cells for the treatment of retinal and neural degenerative diseases; and therapeutic applications of stem cells to treat orthopedic diseases, injuries, and cancer. The company also markets stem cell products, including ESpan cell growth media designed for the growth of human embryonic progenitor cells; approximately 100 progenitor cell types made using the ACTCellerate technology; and an array of human embryonic stem cell lines carrying inherited genetic diseases, such as cystic fibrosis and muscular dystrophy through Embryome.com Website to universities and biomedical companies for research purposes. In addition, BioTime develops blood plasma volume expanders, blood replacement solutions for hypothermic (low temperature) surgery, and technology for use in surgery, emergency trauma treatment, and other applications. Its lead blood plasma expander product, Hextend, is a physiologically balanced intravenous solution that maintains circulatory system fluid volume and blood pressure, and keeps vital organs perfused during surgery and trauma care. In addition, the company is developing another blood volume replacement product, PentaLyte, formulated to maintain the patients tissue and organ function by sustaining the patients fluid volume and physiological balance. BioTime, Inc. was founded in 1990 and is headquartered in Alameda, California.

About BUYINS.NET

BUYINS.NET, www.buyins.net , monitors trading in all US stocks in real time and maintains massive databases of short sale and naked short sale time and sales data, short squeeze SqueezeTrigger prices, market-maker price movements, shareholder data, statistical data on earnings, sector correlation, seasonality, hedge fund trading strategies, comparable valuations. Reports include:

REGULATORY & COMPLIANCE NEWS

Friction Factor market-maker surveillance system tracking Level II market-makers in all stocks to determine Price Friction and compliance with new "Fair Market-Making Requirements"

RegSHO Naked Shorts -- tracks EVERY failure to deliver in all US stocks and tracks all Threshold Security Lists daily for which stocks have naked shorts that are not in compliance with Regulation SHO

INVESTMENTS & TRADING

SqueezeTrigger -- 30 billion cell database tracks EVERY short sale (not just total short interest) in all US stocks and calculates volume weighted price that a short squeeze will begin in each stock.

Earnings Edge -- predicts probability, price move and length of move before and after all US stock earnings reports.

Seasonality -- predicts probability, price move and length of move based on exact time of year for all US stocks.

Group Trader -- tracks sector rotation and stock correlation to its sector and predicts future moves in ALL sectors and industry groups.

Pattern Scan -- automates tracking of every technical pattern and predicts time and size of move in all stocks.

GATS (Global Automated Trading System) -- tracks all known trading strategies and qualifies and quantifies which are working best in real time.

DISCLAIMER:

BUYINS.NET is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell any securities. BUYINS.NET has not been compensated by any of the above mentioned companies specifically for this report, but may have been compensated up to $1,200 per month in the past for unrelated data or report services. Past performance is not indicative of future results. Please visit our web site, www.buyins.net , for complete risks and disclosures.

Contact: BUYINS.NET Thomas Ronk 800-715-9999 tom@buyins.net http://www.buyins.net